TRONCI, ELISABETTA
 Distribuzione geografica
Continente #
EU - Europa 85.372
NA - Nord America 4.243
AS - Asia 1.402
SA - Sud America 209
Continente sconosciuto - Info sul continente non disponibili 185
AF - Africa 47
OC - Oceania 3
Totale 91.461
Nazione #
IT - Italia 84.427
US - Stati Uniti d'America 4.161
SG - Singapore 550
CN - Cina 478
UA - Ucraina 246
DE - Germania 208
SE - Svezia 175
BR - Brasile 167
VN - Vietnam 115
FI - Finlandia 84
GB - Regno Unito 73
FR - Francia 67
HK - Hong Kong 52
CA - Canada 49
KR - Corea 43
IN - India 37
RU - Federazione Russa 31
IQ - Iraq 21
AR - Argentina 18
BD - Bangladesh 16
JP - Giappone 16
BE - Belgio 12
NL - Olanda 12
IL - Israele 11
MX - Messico 11
PK - Pakistan 10
ZA - Sudafrica 10
CZ - Repubblica Ceca 9
CL - Cile 8
ES - Italia 8
ID - Indonesia 8
KE - Kenya 8
SC - Seychelles 8
TR - Turchia 8
AE - Emirati Arabi Uniti 6
EG - Egitto 6
SA - Arabia Saudita 6
GT - Guatemala 5
JM - Giamaica 5
MA - Marocco 5
EC - Ecuador 4
PL - Polonia 4
TH - Thailandia 4
VE - Venezuela 4
CO - Colombia 3
CR - Costa Rica 3
EU - Europa 3
MY - Malesia 3
NI - Nicaragua 3
PY - Paraguay 3
TN - Tunisia 3
AT - Austria 2
AU - Australia 2
BG - Bulgaria 2
CW - ???statistics.table.value.countryCode.CW??? 2
DZ - Algeria 2
EE - Estonia 2
IE - Irlanda 2
JO - Giordania 2
KH - Cambogia 2
KZ - Kazakistan 2
OM - Oman 2
PR - Porto Rico 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
GE - Georgia 1
HN - Honduras 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
MT - Malta 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 91.281
Città #
Cagliari 80.803
Uta 3.423
Ashburn 471
Fairfield 420
Woodbridge 360
Singapore 269
San Jose 217
Chandler 212
Ann Arbor 201
Houston 184
Wilmington 180
Seattle 153
Cambridge 151
Jacksonville 129
Dallas 128
Nyköping 126
Boardman 118
Beijing 117
Dearborn 108
Council Bluffs 64
Santa Clara 60
Los Angeles 58
Shanghai 55
Nanjing 53
New York 46
Hong Kong 45
Ho Chi Minh City 42
The Dalles 42
Helsinki 41
Seoul 40
Lauterbourg 37
Milan 27
Boston 24
Hefei 23
San Diego 23
Hanoi 22
São Paulo 19
Munich 17
Buffalo 15
Guangzhou 14
Phoenix 14
Tokyo 13
Dong Ket 12
Tianjin 12
Toronto 12
Verona 12
Brussels 11
Changsha 11
Nanchang 11
Redwood City 11
Shenyang 11
Brooklyn 10
Chicago 10
Frankfurt am Main 10
Mountain View 10
Orem 10
San Francisco 10
Sassari 10
Hebei 9
Montreal 9
London 8
Norwalk 8
Oristano 8
Redondo Beach 8
Baghdad 7
Chennai 7
Columbus 7
Falls Church 7
Hangzhou 7
Nairobi 7
New Delhi 7
Rome 7
Turku 7
Washington 7
Atlanta 6
Brno 6
Da Nang 6
Jinan 6
Johannesburg 6
Padova 6
Philadelphia 6
Princeton 6
Central 5
Detroit 5
Kingston 5
Stockholm 5
Ankara 4
Brasília 4
Denver 4
Edinburgh 4
Florence 4
Grottammare 4
Jiaxing 4
Lahore 4
Lexington 4
Mexico City 4
Naples 4
Newark 4
Ningbo 4
Orange 4
Totale 88.981
Nome #
5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction 5.865
Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease. 4.364
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease 4.312
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 4.101
Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia 3.711
Effect of selective and non-selective serotonin receptor activation on l-DOPA-induced therapeutic efficacy and dyskinesia in parkinsonian rats 3.596
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 3.568
The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation 3.493
null 2.940
Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats 2.891
The serotonergic system in levodopa-induced dyskinesia 2.608
Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia 2.605
Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding 2.393
null 2.298
5-HT1 receptor agonists for the treatment of L-DOPA-induced dyskinesia: From animal models to clinical investigation 2.266
null 2.247
Foetal cell transplantation for Parkinson's disease: focus on graft-induced dyskinesia 2.217
Serotonin system implication in L-DOPA-induced dyskinesia: from animal models to clinical investigations 2.197
Role of serotonin neurons in L-DOPA- and graft-induced dyskinesia in a rat model of parkinson's disease 2.192
Amphetamine-induced rotation and L-DOPA-induced dyskinesia in the rat 6-OHDA model: A correlation study 2.188
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug 2.127
Caffeine consumption and changes in the function of dopaminergic transmission: evidence of a hyperdopaminergic state in rats subchronically treated with caffeine 1.832
Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and5-HT1B receptor agonists in the rat Parkinson model 1.566
null 1.471
BDNF Overexpression Increases Striatal D3Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia 1.432
Long-term increase in GAD67 mRNA expression in the central amygdala of rats sensitized by drugs and stress 1.327
Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats 1.305
Caffeine sensitization and cross-sensitization with amphetamine: association to post-synaptic changes in rat striatal neurons 1.282
Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats 1.202
null 1.194
Dopamine and adenosine receptor interaction as the basis for the treatment of Parkinson's disease 1.138
Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease 1.118
Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms 1.111
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease 1.090
CAFFEINE SESITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST-SYNAPTIC CHANGES IN RAT STRIATAL NEURONS 1.059
CAFFEINE SENSITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST BUT NOT PRE-SYNAPTIC CHANGES IN RAT STRIATAL NEURON 1.055
null 1.012
Changes in the expression of tonic and phasic neurochemical markers of activity in a rat model of L-DOPA induced dyskinesia 996
Changes in the expression of tonic and phasic neurochemical markers of activity in a rat model of L-DOPA induced dynskinesia 970
null 967
Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats 953
5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model 919
Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment 894
BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats 716
Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons 341
Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats 332
Totale 91.461
Categoria #
all - tutte 111.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.214


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.477 0 0 0 0 253 273 204 158 271 431 492 395
2022/20235.396 358 594 582 451 475 603 302 358 408 422 567 276
2023/20245.792 231 177 232 295 539 859 907 389 223 409 613 918
2024/202517.280 4.890 4.650 4.172 1.181 592 638 702 55 129 76 90 105
2025/20262.654 194 95 259 216 184 174 701 135 175 273 165 83
2026/2027776 54 92 278 294 58 0 0 0 0 0 0 0
Totale 91.461